[Peritumor interstitial double nuclide-double compound lymphoscintigraphy in the noninvasive detection of lymphatic metastases in tumors in the area of the face, skull and mouth cavities].
D000328:Adult; D000368:Aged; D000965:Antimony; D003102:Colloids; D005153:Facial Neoplasms / Q000000981:diagnostic imaging*; D005260:Female; D005710:Gallium Radioisotopes; D006801:Humans; D008198:Lymph Nodes / Q000000981:diagnostic imaging*; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D012888:Skull Neoplasms / Q000000981:diagnostic imaging*; D013667:Technetium; D017556:Technetium Compounds
D003102:Colloids; D005710:Gallium Radioisotopes; D017556:Technetium Compounds; C019096:technetium Tc 99m antimony sulfide; D013667:Technetium; D000965:Antimony
Peritumoral-interstitielle Doppelnuklid-Doppelcompound-Lymphoszintigraphie (PIDDL) zum nichtinvasiven Nachweis von Lymphknotenmetastasen bei Malignomen in Gesichts-, Schädel- und Mundhöhlenbereich.